British Columbia, Canada-based Tilray is recalling new batches of medical cannabis extracts in Germany because of incorrect THC content, German independent pharmaceutical newspaper DAZ reported.
It is the second product recall for Tilray this summer.
According to DAZ, Tilray recalled a total of six batches, all of the same product: THC10:CBD10.
The extract is a 25 millilitre full-spectrum oil with 10 milligrams per millilitre of THC and 10 milligrams per millilitre of CBD.
The affected batches were distributed to Tilray’s pharmaceutical wholesaler in Germany and to German pharmacies between March and May, DAZ reported.
The recalls are likely to affect the Canadian producer financially, as pharmacies should destroy affected products and receive new ones for free.
Tilray did not immediately reply a Marijuana Business Daily inquiry asking, among other things, the size of the batches.
